Author:
Bajo A M,Schally A V,Groot K,Szepeshazi K
Publisher
Springer Science and Business Media LLC
Reference47 articles.
1. Arencibia JM, Schally AV, Krupa M, Bajo AM, Nagy A, Szepeshazi K, Plonowski A (2001) Targeting of doxorubicin to ES-2 human ovarian cancers in nude mice by linking to an analog of luteinizing hormone-releasing hormone improves its effectiveness. Int J Oncol 19: 571–577
2. Bagheri-Yarmand R, Vadlamudi RK, Wang RA, Mendelsohn J, Kumar R (2000) Vascular endothelial growth factor up-regulation via p21-activated kinase-1 signaling regulates heregulin-β-1-mediated angiogenesis. J Biol Chem 275: 39451–39457
3. Bajo AM, Schally AV, Krupa M, Hebert F, Groot K, Szepeshazi K (2002) Bombesin antagonists inhibit growth of MDA-MB-435 estrogen-independent breast cancers and decrease the expression of the ErbB-2/HER-2 oncoprotein and c-jun and c-fos oncogenes. Proc Natl Acad Sci USA 19: 3836–3841
4. Beno DW, Brady LM, Bissonnette M, Davis BH (1995) Protein kinase C and MAP kinase are required for 1, 24-dihydroxy-vitamin D3 stimulation of EGR induction. J Biol Chem 270: 3642–3647
5. Bernhardt G, Reile H, Birnbock H, Sprub T, Schonenberger H (1992) Standard kinetic microassay to quantify differential chemosensitivity on the basis of proliferative activity. J Cancer Res Clin Oncol 118: 35–43
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献